drugset / Trial / NCT01443689

Allogenic Stem Cell Therapy in Patients With Acute Burn

NCT01443689

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Burn trauma,especially extensive ones, remains a life-threatening local and general inflammatory condition destroying the skin and underlying tissues, and resulting in serious sequelae. Remarkable progress has been achieved during last 30 years,stem cell therapy plays an important role in this progress. Human umbilical cord mesenchymal stem cells (hUCMSCs) and human cord blood mononuclear cells (hCBMNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis, suggesting the novel and promising therapeutic strategy for burn. In this study, the safety and efficacy of hUCMSCs and hCBMNCs transplantation will be evaluated in patients with acute burn.

Timeline

Start
2011-07
Primary completion
2013-03
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject human cord blood mononuclear cells Cell therapy
Subject human umbilical cord mesenchymal stem cells Cell therapy

Indications

No indication recorded.